Questioning Chemotherapy

Google+ Pinterest LinkedIn Tumblr +

Most of the protests “chemo” was that these drugs do not discriminate between normal and tumor cells, but attacked all rapidly dividing cells. One scientist has described this method of “trying to digest the patient’s left ear, leaving the right hand alone.” Seemed particularly inappropriate in the treatment of solid tumors in adults, often are slow growing.

Because chemotherapy drugs were general cellular poisons, they could be terribly toxic. They were also very expensive for patients and society as a whole. When I learned about the relationship between the pharmaceutical industry and the creation of cancer (later detailed in my book, The significance r Industry) I understood the business reason for such a mode of failure been so strongly encouraged.

In 1989, a biostatistician German named Ulrich Abel, Ph.D. has published a monograph titled innovative “advanced epithelial cancer chemotherapy. He took a few waves in the United States, and soon went to print. For her, however, Dr. Abel firmly demonstrated that chemotherapy has never been scientifically proven to extend the life of randomized clinical trials (RCT) is the most “epithelial tumors. “These are the most common cancer in those most affected by cancer patients in Western countries.

A few years later, in response to many requests, I decided to write a book critical of chemotherapy (a type of document to the cancer therapy). Abel took out of the working copy as a starting point, but also consult the work of many other students of chemotherapy. In this book, update statistics and talk about all cancers, not only to carcinomas. I go into depth about politics and economics of the industry’s chemotherapy, prejudice, sophistry and fraud to occur, and how to avoid catastrophic side effects sometimes accompany treatment.

The main point of the book is that we must question the extent of success of chemotherapy. Oncologists tend to equate an increasing percentage of “responses” with progress. However, the responses are generally tumor reduction measures for a period of just one month. You can not automatically assume that the answer – although a complete response – leading to greater survival. We must seek survival has increased. However, the number of cancers for which it has been a life extension through chemotherapy demonstrated by randomized clinical trials is very low. (Do not bend over backwards to indicate when they occur.)

So when the doctor says that his treatment produces a 40 percent response rate “, what’s promising short-term tumor shrinkage – or real life extension, and what effect this treatment is likely to be the quality of patient’s life and what it costs? ” Only by obtaining information, such as this, that the patients to make rational treatment options. Chemotherapy in question is designed to help patients by providing them with a critical aspect of this now dominant mode.


About Author

Leave A Reply